MedTrace Logo

First Report, Five Years Experience of the Acute Leukemia Work Group

NCT02990104 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-12-13

No results posted yet for this study

Summary

The purpose of this study is to describe the incidence, clinic characteristics, biological and suvirval in Lymphoblastic Leukemia patients in Mexico City reference hospitals.

Conditions

  • Acute Leukemia (Category)

Sponsors & Collaborators

  • Amgen

    collaborator INDUSTRY

  • Mexican Agrupation for Hematology Study

    lead OTHER

Principal Investigators

  • Dr. Erick Crespo, Doctor · Regional Hospital High Speciality, Tamaulipas Cd. Victoria

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-01-31
Completion
2017-07-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02990104 on ClinicalTrials.gov